Back to all Insights
Clinical Innovations Apr 05, 2026

The Role of Artificial Intelligence in Early Glaucoma Detection

VA
Dr. Victor Akaeze Founder & CEO

Artificial intelligence is shifting the glaucoma paradigm from reactive treatment to proactive intervention. We explore how deep learning algorithms are currently applied to OCT scans and visual fields.

Glaucoma is characterized by a slow, insidious progression that frequently evades early detection using standard clinical measures. By the time visual field loss is definitively mapped, the structural deficit is already profound.

Deep Learning on OCT Scans

Convolutional Neural Networks (CNNs) trained on tens of thousands of Optical Coherence Tomography (OCT) images are now capable of detecting RNFL thinning significantly earlier than human evaluators. By recognizing micro-patterns in the ganglion cell complex and identifying asymmetric normative drop-offs, AI models act as a microscopic second opinion.

"An AI does not get fatigued after reviewing 40 charts in a single day. It analyzes the 41st OCT scan with the exact same mathematical precision as the first."

Integrating AI into the Clinic

The Glaucoma One platform utilizes advanced OCR and data-parsing algorithms to seamlessly ingest these structural metrics alongside functional perimetry data. The true power of AI in glaucoma is not replacing the clinician, but synthesizing massive, disparate longitudinal datasets into a single, highly actionable actuarial trajectory.